Q3 2025 Management View CEO A. Kazimi announced a new strategic agreement: "We've entered into arrangements with RedHill ...

This analysis reviews the history and current status of biosimilar regulation in the US, concluding that changing the FDA’s interchangeability standards—as proposed by some policy makers—is a ...

FDA announces major reforms to streamline biosimilar approvals, potentially saving Americans billions on prescription drug ...

Global plastics production and exports have expanded rapidly over the past seven decades, with countries such as the U.S., ...

European leaders are cancelling attendance at next week’s EU-CELAC summit in Santa Marta after the U.S. sanctioned Colombian ...

Cristiano Ronaldo Jr. made his Portugal U-16 debut on October 31, 2024, during a 2-0 win over Turkey, entering in stoppage time.

Trump administration officials pledged Monday that major reforms for biosimilar drug approvals will expand access and lower ...

Q3 2025 Sales Call November 4, 2025 9:00 AM ESTCompany ParticipantsHugues Chomel - Deputy Chief Executive Officer of ...

AAM, the Biosimilars Council and NACDS commended the FDA for its announcement to make it faster and less costly to develop biosimilar medicines.

PostNL NV (PSTNY) reports steady revenue growth and strategic advancements, while addressing regulatory and market challenges in Q3 2025.

President Bola Tinubu has emphasised the importance of local production in stabilising supply chains and strengthening the ...